<DOC>
	<DOCNO>NCT01578278</DOCNO>
	<brief_summary>This clinical study evaluate safety efficacy bepotastine besilate-corticosteroid combination nasal spray treatment seasonal allergic rhinitis ( SAR ) subject demonstrated history Mountain Cedar pollen allergy . The primary study objective ass reduction baseline average morning ( AM ) evening ( PM ) value reflective total nasal symptom score 3 nasal spray ( bepotastine besilate-fluticasone propionate combination nasal spray , bepotastine besilate nasal spray , fluticasone propionate nasal spray ) compare placebo nasal spray . For enrolled subject , study involve 7-10 day run-in screening period dose placebo nasal spray 14-day treatment period subject dose twice day 1 4 test agent nasal spray record reflective instantaneous score nasal ocular symptom prior dose .</brief_summary>
	<brief_title>Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared Placebo , Bepotastine Besilate Nasal Spray , Corticosteroid Nasal Spray Treatment Patients With Seasonal Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Male female least 12 year age demonstrate history Mountain Cedar pollen allergy No active nasal infection nasal abnormality would affect subject safety symptom assessment</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>